Intracranial atherosclerosis in pseudoxanthoma elasticum: A case-control study.


Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
06 2022
Historique:
received: 20 12 2021
revised: 08 04 2022
accepted: 13 04 2022
pubmed: 26 4 2022
medline: 7 6 2022
entrez: 25 4 2022
Statut: ppublish

Résumé

Pseudoxanthoma elasticum (PXE) is a genetic disorder characterized by systemic calcification of elastin fibers. Additionally, PXE is associated with an increased risk of stroke. It has been hypothesized that this may be caused by accelerated (intracranial) atherogenesis, as a consequence of specific genetic mutations underlying PXE. Hence, we compared the distribution and burden of intracranial atherosclerosis between PXE patients and healthy controls. Fifty PXE patients and 40 age-and-sex-matched healthy controls (without previous ischemic cerebrovascular disease) underwent 3T MRI to visualize atherosclerotic intracranial vessel wall lesions (VWLs). We compared the presence and burden of VWLs (total and for the anterior cerebral, middle cerebral, intracranial internal carotid, posterior cerebral, and basilar arteries separately) between PXE patients and healthy controls using logistic (presence versus absence) and negative binomial regression models (VWL count) adjusted for relevant confounders. All regressions included group (PXE patients vs. healthy controls) as independent variable. We found that 34 (68.0%) PXE patients and 28 (70.0%) healthy controls had a VWL (odds ratio for presence 1.06 [95%CI 0.38-2.91]). In addition, the total burden of VWLs was similar between PXE patients (68 VWLs) and healthy controls (73 VWLs, incidence rate ratio for count 0.81 [95%CI 0.55-1.20]). Findings were similar when analyses were stratified for artery. The distribution and burden of intracranial atherosclerosis were similar between PXE patients and healthy controls. This implies PXE and its underlying mutations do not involve increased (intracranial) atherogenesis and that vascular calcification or other mechanisms explains the increased stroke risk in PXE.

Sections du résumé

BACKGROUND AND AIMS
Pseudoxanthoma elasticum (PXE) is a genetic disorder characterized by systemic calcification of elastin fibers. Additionally, PXE is associated with an increased risk of stroke. It has been hypothesized that this may be caused by accelerated (intracranial) atherogenesis, as a consequence of specific genetic mutations underlying PXE. Hence, we compared the distribution and burden of intracranial atherosclerosis between PXE patients and healthy controls.
METHODS
Fifty PXE patients and 40 age-and-sex-matched healthy controls (without previous ischemic cerebrovascular disease) underwent 3T MRI to visualize atherosclerotic intracranial vessel wall lesions (VWLs). We compared the presence and burden of VWLs (total and for the anterior cerebral, middle cerebral, intracranial internal carotid, posterior cerebral, and basilar arteries separately) between PXE patients and healthy controls using logistic (presence versus absence) and negative binomial regression models (VWL count) adjusted for relevant confounders. All regressions included group (PXE patients vs. healthy controls) as independent variable.
RESULTS
We found that 34 (68.0%) PXE patients and 28 (70.0%) healthy controls had a VWL (odds ratio for presence 1.06 [95%CI 0.38-2.91]). In addition, the total burden of VWLs was similar between PXE patients (68 VWLs) and healthy controls (73 VWLs, incidence rate ratio for count 0.81 [95%CI 0.55-1.20]). Findings were similar when analyses were stratified for artery.
CONCLUSIONS
The distribution and burden of intracranial atherosclerosis were similar between PXE patients and healthy controls. This implies PXE and its underlying mutations do not involve increased (intracranial) atherogenesis and that vascular calcification or other mechanisms explains the increased stroke risk in PXE.

Identifiants

pubmed: 35468517
pii: S0021-9150(22)00193-9
doi: 10.1016/j.atherosclerosis.2022.04.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-24

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Carlo Lucci (C)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Tim C van den Beukel (TC)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Jonas W Bartstra (JW)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Jaco Zwanenburg (J)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Anja van der Kolk (A)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands; Dept. of Radiology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, the Netherlands.

Richard Takx (R)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Jeroen Hendrikse (J)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Mirjam I Geerlings (MI)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, the Netherlands.

Daniel Bos (D)

Department of Vascular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands; Department of Epidemiology, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Wilko Spiering (W)

Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.

Pim A de Jong (PA)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands. Electronic address: p.deJong-8@umcutrecht.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH